Delivery Order SPE2DB20D7059-SPE2DB24FQMK6

Award Date 9/9/24
Potential Completion Date 9/10/24
Potential Value $2.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division for the delivery of INSULIN ASPART 100 UNIT/ML VL 10ML. The contract has a ceiling value of $5,022.93 and is a Firm Fixed Price Delivery Order with a period of performance through May 24, 2024. The contract is not associated with any set-aside designation. Amerisourcebergen, a large pharmaceutical distribution company, holds a significant Indefinite Delivery...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,728,805 milliliters of INSULIN ASPART 100 UNIT/ML PEN 3ML. The order is valued at $49,967.72 and has a completion date of February 22, 2024. Amerisourcebergen Drug Corp is the prime contractor and does not have any major subcontractors listed. This delivery order is part of a larger indefinite delivery contract (IDC)...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division provides for the delivery of INSULIN ASPART 100 UNIT/ML VL 10ML medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,272.60, is a Delivery Order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, which has a ceiling value of up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as Amerisourcebergen's...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of Insulin Aspart 100 Unit/mL in 10mL vials, with a completion date of January 26, 2024 and a potential value of $1,052.66. Amerisourcebergen Drug Corp holds an indefinite delivery contract with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $10,637.56 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,298,990 units of Insulin Aspart 100 Unit/mL pen 3mL. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. The IDC allows the DLA to efficiently procure a...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract, valued at $2,822.60, is for the delivery of Insulin Aspart 100 Unit/ML Vials 10ML to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $2,562.72 fixed-price contract is for the provision of Insulin Aspart 100 Unit/mL 10mL vials, with a performance period ending on May 24, 2024. Amerisourcebergen, a major pharmaceutical distributor, has an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with DLA Troop Support Medical, which serves as the primary vehicle for the...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of INSULIN ASPART 100 UNIT/ML VL 10ML, a critical medical commodity for federal healthcare programs. The contract has a Firm Fixed Price pricing type and a Ceiling Value of $7,029.23. It was awarded on February 5, 2025, with a completion date of February 6, 2025. The contract is not designated...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $6,586.56 firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide 4563456132 - INSULIN ASPART 100 UNIT/ML PEN 3ML. This delivery order is part of an indefinite delivery contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to deliver pharmaceutical products and medical supplies to military treatment facilities worldwide. The contract does not...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of insulin aspart medication in 10 mL vials. The $9,896.55 delivery order contract, placed by the Defense Logistics Agency (DLA), has a firm fixed price and an ultimate completion date of April 22, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a wide range of...
  • SPE2DB20D7059
    Indefinite Delivery Contract
  • SPE2DB20D7059-SPE2DB24FQMK6
    Delivery Order

The Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract to Amerisourcebergen Drug Corp Corporate Office Division to supply 4565723173 - INSULIN ASPART 100 UNIT/ML VL 10ML. The contract has a ceiling value of $2,545.20 and an ultimate completion date of September 10, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical, valued up to $999,999,999, and the Department of Justice Federal Bureau of Investigation, valued up to $750,000, to provide a wide range of medical commodities, including critical care materials and prescription drugs, to support federal healthcare programs and facilities. This delivery order is not associated with a set-aside program.

Generated 12/9/24, 1:56 PM